Stock Earnings

Question 1

Gyre Therapeutics Incの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、Gyre Therapeutics Incの総資産は$125で、純profitは$12です。

Question 2

GYREの主要な財務比率は何ですか？

Accepted Answer

Gyre Therapeutics Incの流動比率は2.01、純利益率は11.42、1株当たり売上高は$1.02です。

Question 3

Gyre Therapeutics Incの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

Gyre Therapeutics Inc largest revenue segment is Gyre Pharmaceuticals, at a revenue of 105,757,000 in the most earnings release.For geography, China is the primary market for Gyre Therapeutics Inc, at a revenue of 105,757,000.

Question 4

Gyre Therapeutics Incは収益を上げていますか？

Accepted Answer

yes、最新の財務諸表によると、Gyre Therapeutics Incの純profitは$12です。

Question 5

Gyre Therapeutics Incに負債はありますか？

Accepted Answer

yes、Gyre Therapeutics Incの負債は62です。

Question 6

Gyre Therapeutics Incの発行済株式数は何株ですか？

Accepted Answer

Gyre Therapeutics Incの総発行済株式数は86.3株です。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	107	105	113	0	7	20
Revenue Growth (YoY)	-44%	-7%	--	-100%	-65%	--
Cost of Revenue	4	3	4	0	7	9
Gross Profit	102	101	108	0	0	11
Selling, General & Admin	77	73	75	16	18	16
Research & Development	12	12	13	12	68	52
Operating Expenses	90	85	89	29	87	68
Other Non Operating Income (Expenses)	2	5	-10	0	0	0
Pretax Income	15	23	-76	-7	-87	-56
Income Tax Expense	3	5	8	0	--	--
Net Income	6	12	-92	-8	-87	-56
Net Income Growth	-108%	-112.99%	1,050%	-91%	55%	2%
Shares Outstanding (Diluted)	103.97	102.29	65.83	2.1	2.04	1.28
Shares Change (YoY)	1%	55%	3,035%	3%	59%	60%
EPS (Diluted)	0.06	0.11	-1.41	-3.92	-43.1	-43.93
EPS Growth	-109%	-108%	-64%	-91%	-2%	-36%
Free Cash Flow	1	-6	17	-33	-84	-55
Free Cash Flow Per Share	0	-0.05	0.25	-15.71	-41.17	-42.96
Gross Margin	95.32%	96.19%	95.57%	0%	0%	55%
Operating Margin	10.28%	15.23%	16.81%	0%	-1,242.85%	-280%
Profit Margin	5.6%	11.42%	-81.41%	0%	-1,242.85%	-280%
Free Cash Flow Margin	0.93%	-5.71%	15.04%	0%	-1,200%	-275%
EBITDA	13	17	20	-29	-87	-56
EBITDA Margin	12.14%	16.19%	17.69%	0%	-1,242.85%	-280%
D&A For EBITDA	2	1	1	0	0	0
EBIT	11	16	19	-29	-87	-56
EBIT Margin	10.28%	15.23%	16.81%	0%	-1,242.85%	-280%
Effective Tax Rate	20%	21.73%	-10.52%	0%	--	--

Gyre Therapeutics Inc (GYRE) Price

GYRE Stock Price Chart

GYRE Income

Follow-Up Questions